• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂耐药和顺铂敏感的睾丸生殖细胞肿瘤细胞系中的差异基因表达

Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines.

作者信息

Roška Jan, Wachsmannová Lenka, Hurbanová Lenka, Šestáková Zuzana, Mueller Thomas, Jurkovičová Dana, Chovanec Miroslav

机构信息

Department of Genetics, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovak Republic.

University Clinic for Internal Medicine IV, Hematology/Oncology, Medical Faculty of Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

出版信息

Oncotarget. 2020 Dec 22;11(51):4735-4753. doi: 10.18632/oncotarget.27844.

DOI:10.18632/oncotarget.27844
PMID:33473258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7771712/
Abstract

Testicular germ cell tumors (TGCTs) represent a well curable malignity due to their exceptional response to cisplatin (CDDP). Despite remarkable treatment results, approximately 5% of TGCT patients develop CDDP resistance and die. Exceptional curability makes TGCTs a highly valuable model system for studying the molecular mechanisms of CDDP sensitivity. Our study was aimed at revealing difference in gene expression between the CDDP-resistant and -sensitive TGCT cell lines, and hence at identifying candidate genes that could serve as potential biomarkers of CDDP response. Using gene expression array, we identified 281 genes that are differentially expressed in CDDP-resistant compared to -sensitive TGCT cell lines. The expression of 25 genes with the highest fold change was validated by RT-qPCR. Of them, , , , , , , , , , , , , , and , displayed comparable expression change in gene expression array and RT-qPCR, when all CDDP-resistant TGCT cell lines were pairwise combined with all -sensitive ones. Products of the identified genes are pluripotency factors, or are involved in processes, such as cell metabolism, proliferation or migration. We propose that, after clinical validation, these genes could serve as prognostic biomarkers for early detection of CDDP response in TGCT patients.

摘要

睾丸生殖细胞肿瘤(TGCTs)因其对顺铂(CDDP)的特殊反应而成为一种可治愈性良好的恶性肿瘤。尽管治疗效果显著,但仍有大约5%的TGCT患者会产生顺铂耐药并死亡。TGCTs极高的治愈率使其成为研究顺铂敏感性分子机制的极具价值的模型系统。我们的研究旨在揭示顺铂耐药和敏感的TGCT细胞系之间的基因表达差异,从而确定可作为顺铂反应潜在生物标志物的候选基因。通过基因表达阵列,我们鉴定出281个在顺铂耐药的TGCT细胞系与敏感细胞系中差异表达的基因。通过RT-qPCR验证了25个变化倍数最高的基因的表达。其中,当所有顺铂耐药的TGCT细胞系与所有敏感细胞系两两组合时, 、 、 、 、 、 、 、 、 、 、 、 、 以及 在基因表达阵列和RT-qPCR中显示出相当的表达变化。所鉴定基因的产物是多能性因子,或参与细胞代谢、增殖或迁移等过程。我们认为,经过临床验证后,这些基因可作为预测生物标志物,用于早期检测TGCT患者的顺铂反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/3052ba46646a/oncotarget-11-4735-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/d5f850fafdc8/oncotarget-11-4735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/fe142cfe2dcc/oncotarget-11-4735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/d596f5de72b4/oncotarget-11-4735-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/1c59c6622b15/oncotarget-11-4735-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/9c185d9b3ad8/oncotarget-11-4735-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/3052ba46646a/oncotarget-11-4735-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/d5f850fafdc8/oncotarget-11-4735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/fe142cfe2dcc/oncotarget-11-4735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/d596f5de72b4/oncotarget-11-4735-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/1c59c6622b15/oncotarget-11-4735-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/9c185d9b3ad8/oncotarget-11-4735-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f40/7771712/3052ba46646a/oncotarget-11-4735-g006.jpg

相似文献

1
Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines.顺铂耐药和顺铂敏感的睾丸生殖细胞肿瘤细胞系中的差异基因表达
Oncotarget. 2020 Dec 22;11(51):4735-4753. doi: 10.18632/oncotarget.27844.
2
Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors.睾丸生殖细胞肿瘤中顺铂耐药的分子基础
Cancers (Basel). 2019 Sep 6;11(9):1316. doi: 10.3390/cancers11091316.
3
Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.顺铂耐药性睾丸生殖细胞肿瘤的潜在新治疗方法。
Front Biosci (Landmark Ed). 2022 Aug 16;27(8):245. doi: 10.31083/j.fbl2708245.
4
Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.基于基因表达谱的顺铂诱导人睾丸癌细胞系反应的分子图谱
Mol Cancer. 2007 Aug 21;6:53. doi: 10.1186/1476-4598-6-53.
5
Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours.节点信号对多能因子表达、肿瘤细胞增殖和睾丸生殖细胞肿瘤中顺铂敏感性的影响。
BMC Cancer. 2020 Apr 23;20(1):349. doi: 10.1186/s12885-020-06820-6.
6
PCPH expression is an early event in the development of testicular germ cell tumors.PCPH表达是睾丸生殖细胞肿瘤发生过程中的早期事件。
Int J Oncol. 2006 Mar;28(3):595-604.
7
Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.胚胎癌细胞中Oct-3/4表达的缺失与顺铂耐药性的诱导相关。
Tumour Biol. 2006;27(2):71-83. doi: 10.1159/000092324. Epub 2006 Mar 24.
8
Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.XPA 水平升高可能是生殖细胞瘤对顺铂耐药的基础。
BMC Cancer. 2020 Jan 6;20(1):17. doi: 10.1186/s12885-019-6496-1.
9
Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.DNA 错配修复系统在顺铂治疗睾丸生殖细胞肿瘤敏感性中的作用。
Cell Oncol (Dordr). 2017 Aug;40(4):341-355. doi: 10.1007/s13402-017-0326-8. Epub 2017 May 23.
10
Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.舒尼替尼在顺铂敏感和顺铂耐药的人睾丸生殖细胞肿瘤原位模型中可抑制肿瘤生长,并与顺铂协同作用。
Clin Cancer Res. 2009 May 15;15(10):3384-95. doi: 10.1158/1078-0432.CCR-08-2170. Epub 2009 May 5.

引用本文的文献

1
PCP4 inhibits the progression of prostate cancer through Ca/CAMKK2/AMPK/AR pathway.PCP4通过Ca/CAMKK2/AMPK/AR途径抑制前列腺癌的进展。
Front Immunol. 2025 Jul 17;16:1616046. doi: 10.3389/fimmu.2025.1616046. eCollection 2025.
2
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors and potential therapeutic agents (Review).睾丸生殖细胞肿瘤中顺铂敏感性和耐药性的机制及潜在治疗药物(综述)
Exp Ther Med. 2025 Feb 24;29(4):82. doi: 10.3892/etm.2025.12832. eCollection 2025 Apr.
3
Mitochondrial genome variability and metabolic alterations reveal new biomarkers of resistance in testicular germ cell tumors.

本文引用的文献

1
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors.组蛋白去乙酰化酶抑制剂贝利司他和帕比司他对顺铂敏感及顺铂耐药性睾丸生殖细胞肿瘤的疗效
Cancers (Basel). 2020 Oct 10;12(10):2903. doi: 10.3390/cancers12102903.
2
Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness.那帕布卡辛通过抑制肿瘤干性克服卵巢生殖细胞肿瘤来源细胞系中的顺铂耐药性。
Cancer Cell Int. 2020 Aug 3;20:364. doi: 10.1186/s12935-020-01458-7. eCollection 2020.
3
Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives.
线粒体基因组变异性和代谢改变揭示了睾丸生殖细胞肿瘤耐药性的新生物标志物。
Cancer Drug Resist. 2024 Dec 18;7:54. doi: 10.20517/cdr.2024.141. eCollection 2024.
4
Emerging roles and biomarker potential of WNT6 in human cancers.WNT6 在人类癌症中的新兴作用和生物标志物潜力。
Cell Commun Signal. 2024 Nov 11;22(1):538. doi: 10.1186/s12964-024-01892-4.
5
The multifaceted role of insulin-like growth factor binding protein 7.胰岛素样生长因子结合蛋白7的多方面作用
Front Cell Dev Biol. 2024 Jul 16;12:1420862. doi: 10.3389/fcell.2024.1420862. eCollection 2024.
6
Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation.六种免疫相关的潜在生物标志物可能改善肝细胞癌预后:一项生物信息学分析及实验验证
Cancer Cell Int. 2023 Mar 23;23(1):52. doi: 10.1186/s12935-023-02888-9.
7
Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.基于集成微阵列的 miRNA 表达谱数据分析:鉴定顺铂耐药的睾丸生殖细胞肿瘤的新型生物标志物。
Int J Mol Sci. 2023 Jan 27;24(3):2495. doi: 10.3390/ijms24032495.
8
Screening for the Key Proteins Associated with Rete Testis Invasion in Clinical Stage I Seminoma via Label-Free Quantitative Mass Spectrometry.通过无标记定量质谱法筛选临床I期精原细胞瘤中与睾丸网浸润相关的关键蛋白
Cancers (Basel). 2021 Nov 8;13(21):5573. doi: 10.3390/cancers13215573.
9
Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance.利用患者来源的上皮性卵巢癌肿瘤类器官预测卡铂耐药性。
Biomedicines. 2021 Aug 16;9(8):1021. doi: 10.3390/biomedicines9081021.
10
Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.差异甲基化 EPIC 分析揭示了配对的原发性和转移性睾丸生殖细胞肿瘤患者组织样本中顺铂耐药相关的高甲基化和肿瘤特异性异质性。
Clin Epigenetics. 2021 Apr 6;13(1):70. doi: 10.1186/s13148-021-01048-y.
睾丸生殖细胞肿瘤中的顺铂耐药性:多视角下的当前挑战
Cancers (Basel). 2020 Jun 17;12(6):1601. doi: 10.3390/cancers12061601.
4
CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms.CDK4/6 抑制为儿科和成人生殖细胞瘤提供了一种治疗选择,并通过经典和非经典机制诱导细胞周期停滞和细胞凋亡。
Br J Cancer. 2020 Aug;123(3):378-391. doi: 10.1038/s41416-020-0891-x. Epub 2020 May 18.
5
IGFBP2 promotes the EMT of colorectal cancer cells by regulating E-cadherin expression.胰岛素样生长因子结合蛋白2通过调节E-钙黏蛋白的表达促进结肠癌细胞的上皮-间质转化。
Int J Clin Exp Pathol. 2019 Jul 1;12(7):2559-2565. eCollection 2019.
6
Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.XPA 水平升高可能是生殖细胞瘤对顺铂耐药的基础。
BMC Cancer. 2020 Jan 6;20(1):17. doi: 10.1186/s12885-019-6496-1.
7
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription.TRIB3 通过抑制 FOXO1 降解和增强 SOX2 转录来支持乳腺癌干细胞特性。
Nat Commun. 2019 Dec 16;10(1):5720. doi: 10.1038/s41467-019-13700-6.
8
Adipose-Derived Mesenchymal Stem Cells Enhance Ovarian Cancer Growth and Metastasis by Increasing Thymosin Beta 4X-Linked Expression.脂肪来源的间充质干细胞通过增加胸腺素β4X连锁表达促进卵巢癌生长和转移。
Stem Cells Int. 2019 Oct 20;2019:9037197. doi: 10.1155/2019/9037197. eCollection 2019.
9
TRIB3 promotes lung cancer progression by activating β-catenin signaling.TRIB3 通过激活β-catenin 信号促进肺癌进展。
Eur J Pharmacol. 2019 Nov 15;863:172697. doi: 10.1016/j.ejphar.2019.172697. Epub 2019 Sep 25.
10
IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.IGFBP2 通过其间充质诱导和 FcγRIIB 磷酸化促进胶质母细胞瘤中的免疫抑制。
PLoS One. 2019 Sep 27;14(9):e0222999. doi: 10.1371/journal.pone.0222999. eCollection 2019.